home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630214.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
34 lines
Document 0214
DOCN M9630214
TI Effect of interferon-alpha therapy in a patient with common variable
immunodeficiency and chronic Epstein-Barr virus infection.
DT 9603
AU Toraldo R; D'Avanzo M; Tolone C; Canino G; Iafusco F; Notarangelo LD;
Ugazio A; Cirillo C; Dipartimento di Pediatrica, II Universita di
Napoli, Italy.
SO Pediatr Hematol Oncol. 1995 Sep-Oct;12(5):489-93. Unique Identifier :
AIDSLINE MED/96093259
AB We report an 18-year-old boy with common variable immunodeficiency who
presented with splenomegaly as well as left axillary and lateral
cervical lymphadenopathy. Main laboratory investigations showed severe
thrombocytopenia. Epstein-Barr virus (EBV) DNA was detected in the
patient's throat-washing specimens and lymph node biopsy. Lymphocytes
from the lymph node biopsy were also positive for EBV nuclear antigen.
Serology for EBV and cytomegalovirus was negative. A therapeutic attempt
with acyclovir did not influence the course of infection. Six months'
treatment with human lymphoblastoid interferon-alpha (IFN alfa) brought
about the normalization of clinical and hematologic conditions.
Detection on throat-washing specimens carried out 1 year after therapy
was negative. Our preliminary experience suggests that human
lymphoblastoid IFN-alpha is a valid alternative in therapy of
immunodeficient EB virus-infected patients.
DE Adolescence Antiviral Agents/*THERAPEUTIC USE Case Report Chronic
Disease Common Variable Immunodeficiency/*THERAPY Herpesviridae
Infections/*THERAPY *Herpesvirus 4, Human Human
Interferon-alpha/*THERAPEUTIC USE Male Tumor Virus Infections/*THERAPY
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).